Cargando…
Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach
Cervical cancer is the second largest cause of cancer-related death in women worldwide, and it occurs following persistent infection, sometimes for decades, with a specific subset of human papillomavirus (HPV) types; the approximately 13 oncogenic subtypes. Prophylactic vaccines against HPV infectio...
Autores principales: | Kawana, Kei, Adachi, Katsuyuki, Kojima, Satoko, Kozuma, Shiro, Fujii, Tomoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547358/ https://www.ncbi.nlm.nih.gov/pubmed/23341862 http://dx.doi.org/10.2174/1874357901206010264 |
Ejemplares similares
-
Multistate Markov Model to Predict the Prognosis of High-Risk Human Papillomavirus-Related Cervical Lesions
por: Taguchi, Ayumi, et al.
Publicado: (2020) -
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
por: Ikeda, Yuji, et al.
Publicado: (2021) -
Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia
por: Baba, Satoshi, et al.
Publicado: (2020) -
PDZ Domains and Viral Infection: Versatile Potentials of HPV-PDZ Interactions in relation to Malignancy
por: Nagasaka, Kazunori, et al.
Publicado: (2013) -
Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
por: Silling, Steffi, et al.
Publicado: (2014)